240 related articles for article (PubMed ID: 12766067)
1. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
[TBL] [Abstract][Full Text] [Related]
2. Orally administered antifungal therapy for experimental keratomycosis.
O'Day DM
Trans Am Ophthalmol Soc; 1990; 88():685-725. PubMed ID: 2095036
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans-induced keratomycosis.
Gyanfosu L; Koffuor GA; Kyei S; Ababio-Danso B; Peprah-Donkor K; Nyansah WB; Asare F
Int Ophthalmol; 2018 Oct; 38(5):2089-2100. PubMed ID: 28900810
[TBL] [Abstract][Full Text] [Related]
4. Topical fluconazole for experimental candida keratitis in rabbits.
Behrens-Baumann W; Klinge B; Rüchel R
Br J Ophthalmol; 1990 Jan; 74(1):40-2. PubMed ID: 2306443
[TBL] [Abstract][Full Text] [Related]
5. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
[TBL] [Abstract][Full Text] [Related]
6. A new long-acting liposomal topical antifungal formula: human clinical study.
Abdel-Rhaman MS; Soliman W; Habib F; Fathalla D
Cornea; 2012 Feb; 31(2):126-9. PubMed ID: 22138587
[TBL] [Abstract][Full Text] [Related]
7. Contact lens-induced infection--a new model of Candida albicans keratitis.
O'Day DM; Head WS; Robinson RD; Yang R; Shetlar D; Wang MX
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1607-11. PubMed ID: 10359345
[TBL] [Abstract][Full Text] [Related]
8. Corneal anesthetic abuse and Candida keratitis.
Chern KC; Meisler DM; Wilhelmus KR; Jones DB; Stern GA; Lowder CY
Ophthalmology; 1996 Jan; 103(1):37-40. PubMed ID: 8628558
[TBL] [Abstract][Full Text] [Related]
9. Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis.
Özdemir HB; Kalkancı A; Bilgihan K; Göçün PU; Öğüt B; Karakurt F; Erdoğan M
Acta Ophthalmol; 2019 Feb; 97(1):e91-e96. PubMed ID: 29862655
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis.
Avunduk AM; Beuerman RW; Warnel ED; Kaufman HE; Greer D
Curr Eye Res; 2003 Feb; 26(2):113-7. PubMed ID: 12815530
[TBL] [Abstract][Full Text] [Related]
11. Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis.
Mahdy RA; Nada WM; Wageh MM
J Ocul Pharmacol Ther; 2010 Jun; 26(3):281-5. PubMed ID: 20565316
[TBL] [Abstract][Full Text] [Related]
12. Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.
Hiraoka T; Kaji Y; Wakabayashi T; Nanbu PN; Okamoto F; Oshika T
Cornea; 2007 Apr; 26(3):336-42. PubMed ID: 17413962
[TBL] [Abstract][Full Text] [Related]
13. Topical Eugenol Successfully Treats Experimental Candida albicans-Induced Keratitis.
Hassan HA; Geniady MM; Abdelwahab SF; Abd-Elghany MI; Sarhan HA; Abdelghany AA; Kamel MS; Rodriguez AE; Alio JL
Ophthalmic Res; 2018; 60(2):69-79. PubMed ID: 29969774
[TBL] [Abstract][Full Text] [Related]
14. Polymicrobial keratomycosis in a three-year-old child.
Parentin F; Liberali T; Perissutti P
Ocul Immunol Inflamm; 2006 Apr; 14(2):129-31. PubMed ID: 16597544
[TBL] [Abstract][Full Text] [Related]
15. Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicans-induced keratomycosis in rabbits.
Pleyer U; Legmann A; Mondino BJ; Lee DA
Am J Ophthalmol; 1992 Mar; 113(3):303-8. PubMed ID: 1543224
[TBL] [Abstract][Full Text] [Related]
16. Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.
Kalkanci A; Yesilirmak N; Ozdemir HB; Unal EA; Erdoğan M; Seker T; Tum AE; Karakus AK; Hizel K; Bilgihan K
Cornea; 2018 Nov; 37(11):1463-1467. PubMed ID: 30161054
[TBL] [Abstract][Full Text] [Related]
17. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
[TBL] [Abstract][Full Text] [Related]
18. Natamycin treatment of experimental Candida albicans induced keratomycosis in rabbits.
Saleem M; Rahman A; Afza N
West Indian Med J; 2007 Dec; 56(6):526-9. PubMed ID: 18646497
[TBL] [Abstract][Full Text] [Related]
19. Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
Habib FS; Fouad EA; Abdel-Rhaman MS; Fathalla D
Acta Ophthalmol; 2010 Dec; 88(8):901-4. PubMed ID: 19681761
[TBL] [Abstract][Full Text] [Related]
20. Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
Spierer O; Dugar J; Miller D; OʼBrien TP
Cornea; 2015 May; 34(5):576-9. PubMed ID: 25826327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
